Emergency surgical and endovascular revascularization in high-surgical risk patients with non-ST segment elevation acute coronary syndrome

Abstract

Background. There is a limited number of studies concerning the results of urgent coronary artery bypass grafting (CABG) in high-surgical risk patients with non-ST elevation acute coronary syndrome. Deficit of an evidence-supported base is related to peculiarities of organization and availability of emergency CABG, the process of decision-making, and a series of tactical and technical aspects of performing this type of intervention within the first 24 hours in high-surgical risk patients with manifest symptoms of ischemia and myocardial lesion in severe multivessel coronary atherosclerosis and involvement of the left coronary artery trunk.

Objective. The purpose of this study was to carry out a comparative analysis of the in-hospital outcomes of emergency surgical and endovascular revascularization (CABG and percutaneous coronary intervention) in high-surgical risk patients with non-ST elevation acute coronary syndrome.

Patients and methods. In our retrospective study with propensity score matching, we analyzed the in-hospital results of CABG (n=67) and percutaneous coronary intervention (n=67) in high-surgical risk patients with non-ST-segment elevation acute coronary syndrome within the first 24 hours after admission. The patients had severe lesions of coronary arteries with a median of the SYNTAX score of 24 points. The endpoints of the study were all-cause mortality, cardiac mortality, myocardial infarction, repeat non-elective revascularizations, and a composite endpoint combining all the above enumerated events. Besides, we evaluated completeness of the scope of myocardial revascularization in the groups.

Results. The patients in the groups were comparable by the main clinical and anamnestic data which was ensured by propensity score matching. The majority of CABGs were performed in conditions of artificial circulation. In the group of percutaneous coronary intervention, the strategy of multivessel and staged stenting was used approximately in a similar proportion (47.8 and 52.2%, respectively). There were no significant differences between the groups of CABG and percutaneous coronary intervention by the endpoints. Mortality from cardiac causes in the groups turned out to be similar, each amounting to 4.5%. CABG was characterized by significantly higher frequency of complete myocardial revascularization as compared with percutaneous coronary intervention: n=62 (92.5%) vs n=48 (71.6%), respectively, p=0.001.

Conclusion. Urgently performed CABG demonstrated comparable with percutaneous coronary intervention in-hospital results of revascularization in high-surgical risk patients with severe multivessel lesions with non-ST elevation-acute coronary syndrome, ensuring fuller scope of myocardial revascularization as compared with percutaneous coronary intervention.

Keywords:emergency myocardial revascularization; non-ST segment elevation acute coronary syndrome; multivessel lesion; coronary artery bypass grafting; percutaneous coronary intervention

Funding. The study had no financial support.

Conflict of interest. The authors declare no conflicts of interest.

Authors’ contribution. Study conception and design – Tarasov R.S., Nishonov A.B.; data collection and handling – Nishonov A.B.; statistical processing – Nishonov A.B.; draft manuscript preparation – Tarasov R.S., Nishonov A.B.; manuscript revision – Tarasov R.S., Kozyrin K.A., Ivanov S.V., Ganykov V.I.

For citation: Nishonov A.B., Tarasov R.S., Kozyrin K.A., Ivanov S.V., Ganykov V.I. Emergency surgical and endovascular revascularization in high-surgical risk patients with non-ST segment elevation acute coronary syndrome. Angiology and Vascular Surgery. Journal named Academician A.V. Pokrovsky. 2022; 28 (3): 77–85. DOI: https://doi.org/10.33029/1027-6661-2022-28-3-77-85 (in Russian)

References

1. Alekyan B.G., Boytsov S.A., Manoshkina E.M., Ganyukov V.I. Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016–2020. Kardiologiia. 2021; 61 (12): 4–15. DOI: http://doi.org/10.18087/cardio.2021.12.n1879 (in Russian)

2. Barbarash O.L., Tarasov R.S., Ganyukov V.I. Acute coronary syndrome in patients with prior coronary artery bypass grafting. Literature review. Russian Journal of Cardiology. 2022; 27 (1): 46–59. DOI: http://doi.org/10.15829/1560-4071-2022-4659 (in Russian)

3. Candela E., Marín F., Rivera-Caravaca J.M., et al. Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines. PLoS One. 2018; 13 (11): e0208069. DOI: http://doi.org/10.1371/journal.pone.0208069

4. Desperak P., Hawranek M., Gąsior P., et al. Long-term outcomes of patients with multivessel coronary artery disease presenting non-ST-segment elevation acute coronary syndromes. Cardiology Journal. 2019; 26 (2): 157–168. DOI: http://doi.org/10.5603/CJ.a2017.0110

5. Collet J-P., Thiele H., Barbato E., et al. ESC Scientific Document Group, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021; 42 (14): 1289–1367. DOI: http://doi.org/10.1093/eurheartj/ehaa575

6.  Hlinomaz O., Motovska Z., Knot J., et al. Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial. Journal of Clinical Medicine. 2021; 10 (21): 5103. DOI: http://doi.org/10.3390/jcm10215103

7. Akiyama Y., Matoba T., Katsuki S., et al. Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2nd-Generation Drug-Eluting Stents. Journal of Atherosclerosis and Thrombosis. 2022; 29 (3): 379–392. DOI: http://doi.org/10.5551/jat.61366

8. Sousa-Uva M., Ahlsson A., Neumann F.J., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Journal of Cardio-Thoracic Surgery. 2018; 55 (1): 4–90. DOI: http://doi.org/10.1093/ejcts/ezy289

9. Alekyan B.G., Grigor’yan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment in the Russian federation (2018). Russian Journal of Endovascular Surgery. 2019; 6 (2 Special issue): 5s–188s. DOI: http://doi.org/10.24183/2409-4080-2019-6-2s (in Russian)

10. Filatova A.Yu., Romasov I.V., Potekhina A.V., et al. The Incidence and Possible Predictors of Coronary Restenosis. Kardiologiia. 2020; 60 (2): 10–16. (in Russian)

11. Neumann A., Vöhringer L., Fischer J., et al. Off-Pump Coronary Artery Bypass Grafting in Acute Coronary Syndrome: Focus on Safety and Completeness of Revascularization. Journal of Thoracic and Cardiovascular Surgery. 2020; 68 (8): 679–686. DOI: http://doi.org/10.1055/s-0039-1677834

12. Kawamoto S., Miyata H., Motomura N., et al. Surgical Outcomes of Isolated Coronary Artery Bypass Grafting for Acute Coronary Syndrome – Based on the Japan Adult Cardiovascular Surgery Database. Circulation Journal. 2017; 82 (1): 123–130. DOI: http://doi.org/10.1253/circj.CJ-17-0561

13. Davierwala P.M., Verevkin A., Leontyev S., et al. Does Timing of coronary artery bypass surgery affect early and long-term outcomes in patients with non-ST-segment-elevation myocardial infarction? Circulation. 2015; 132 (8): 731–740. DOI: http://doi.org/10.1161/CIRCULATIONAHA.115.015279

14. Desperak P., Hawranek M., Hrapkowicz T., et al. Comparison of multivessel percutaneous coronary intervention and coronary artery bypass grafting in patients with severe coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes. Kardiologia Polska. 2018; 76 (10): 1474–1481. DOI: http://doi.org/10.5603/KP.a2018.0151

15. Huckaby L.V., Sultan I., Mulukutla S., et al. Revascularization following non-ST elevation myocardial infarction in multivessel coronary disease. Journal of Cardiac Surgery. 2020; 35 (6): 1195–1201. DOI: http://doi.org/10.1111/jocs.14539

16. Ram E., Sternik L., Klempfner R., et al. Outcomes of different revascularization strategies among patients presenting with acute coronary syndromes without ST elevation. Journal of Thoracic and Cardiovascular Surgery. 2020; 160 (4): 926–935.e6. DOI: http://doi.org/10.1016/j.jtcvs.2019.08.130

  • Российское Общество ангиологов и сосудистых хирургов
  • ВКонтакте
  • Telegram
CHIEF EDITOR
Akchurin Renat Suleymanovich
Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Sciences, Deputy General Director for Surgery, Head of the Department of Cardiovascular Surgery, National Medical Research Center for Cardiology named after Academician E.I. Chazov, President of the Russian Society of Angiologists and Vascular Surgeons

 

In accordance with the decision of the Presidium of the Russian Society of Angiologists and Vascular Surgeons, the journal "Angiology and Vascular Surgery" will be named after Academician A.V. Pokrovsky starting from No. 2/2022.


Журналы «ГЭОТАР-Медиа»